Literature DB >> 15249360

Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.

Raj K Maturi1, Minzhong Yu, Richard G Weleber.   

Abstract

OBJECTIVES: To observe the long-term effects of hydroxychloroquine sulfate on retinal electrical activity by multifocal electroretinography (mfERG) and to evaluate the regional variation of retinal dysfunction in subjects with hydroxychloroquine retinopathy.
METHODS: Multifocal ERG with 103-hexagon stimulation was performed on 19 patients (36 eyes) treated with hydroxychloroquine for systemic lupus erythematosus, rheumatoid arthritis, or localized atypical scleroderma. Visual acuity testing, Amsler grid testing, and Ishihara color vision testing were also performed. In 2 of the patients, hydroxychloroquine was discontinued due to concerns about toxicity. Both of these patients had additional mfERG performed after discontinuation of medication.
RESULTS: Twelve patients (19 eyes) had a normal response density in one or both eyes, including 6 patients (12 eyes) with a low lifetime dose (< or =438 g) of hydroxychloroquine who had normal response densities in both eyes. Eleven patients (17 eyes) had abnormal response densities in one or both eyes, and 2 of these patients (4 eyes) had significant attenuation of response densities in almost the whole tested field; 4 patients had a normal mfERG result for one eye but had a slight decrease of response densities for the other eye. There were 4 patterns of abnormal mfERG amplitude change observed: (1) paracentral loss, (2) foveal loss, (3) peripheral loss, and (4) generalized loss. Implicit times were abnormal for pericentral responses in 3 patients. The results of color vision and Amsler grid testing were normal, except for one patient with a generalized loss pattern. In 2 subjects in whom hydroxychloroquine toxicity was suspected, response densities improved after termination of hydroxychloroquine.
CONCLUSIONS: Long-term hydroxychloroquine use may be associated with mfERG abnormalities. The mfERG appears to detect retinal physiological change earlier than visual acuity testing, color vision testing, or Amsler grid testing can. The greatest value of the mfERG is in differentiating a retinal cause and, hence, providing important evidence for hydroxychloroquine toxicity, for whatever visual field loss is apparent on perimetry.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15249360     DOI: 10.1001/archopht.122.7.973

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  30 in total

1.  Hydroxychloroquine screening.

Authors:  A G Lee
Journal:  Br J Ophthalmol       Date:  2005-05       Impact factor: 4.638

2.  Visual field and multifocal electroretinography and their correlations in patients on hydroxychloroquine therapy.

Authors:  Timothy Y Y Lai; Jasmine W S Ngai; Wai-Man Chan; Dennis S C Lam
Journal:  Doc Ophthalmol       Date:  2006-06-28       Impact factor: 2.379

3.  High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy.

Authors:  Julio A Rodriguez-Padilla; Thomas R Hedges; Bryan Monson; Vivek Srinivasan; Maciej Wojtkowski; Elias Reichel; Jay S Duker; Joel S Schuman; James G Fujimoto
Journal:  Arch Ophthalmol       Date:  2007-06

4.  Influence of chloroquine intake on the multifocal electroretinogram in patients with and without maculopathy.

Authors:  Richard Bergholz; Klaus Rüther; Jan Schroeter; Christoph von Sonnleithner; Daniel J Salchow
Journal:  Doc Ophthalmol       Date:  2015-01-31       Impact factor: 2.379

5.  Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography.

Authors:  Susann Missner; Ulrich Kellner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-04       Impact factor: 3.117

6.  A comparative study of the usefulness of color vision, photostress recovery time, and visual evoked potential tests in early detection of ocular toxicity from hydroxychloroquine.

Authors:  Javad Heravian; Massoud Saghafi; Naser Shoeibi; Samira Hassanzadeh; Mohammad Taghi Shakeri; Maria Sharepoor
Journal:  Int Ophthalmol       Date:  2011-07-12       Impact factor: 2.031

7.  Validation of the colour difference plot scoring system analysis of the 103 hexagon multifocal electroretinogram in the evaluation of hydroxychloroquine retinal toxicity.

Authors:  Gabrielle S Graves; Murtaza K Adam; Kimberly E Stepien; Dennis P Han
Journal:  Acta Ophthalmol       Date:  2014-02-07       Impact factor: 3.761

8.  Early morpho-functional changes in patients treated with hydroxychloroquine: a prospective cohort study.

Authors:  Giulio Ruberto; Carlo Bruttini; Carmine Tinelli; Lorenzo Cavagna; Alessandro Bianchi; Giovanni Milano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-08-27       Impact factor: 3.117

Review 9.  Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates.

Authors:  Radouil Tzekov
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

10.  Retinal toxicity related to hydroxychloroquine in patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Hande Husniye Telek; Nilufer Yesilirmak; Gulten Sungur; Yaprak Ozdemir; Nesibe Karahan Yesil; Firdevs Ornek
Journal:  Doc Ophthalmol       Date:  2017-08-29       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.